Details van artikel 204 van 305 gevonden artikelen
Palifermin reduces severe oral mucositis (OM), improves patient quality of life, and reduces health resource use in patients with hematologic malignancies receiving high-dose chemotherapy (HDCT) and total body irradiation (TBI) with autologous peripheral blood stem cell (PBSC) support: results from a phase III trial
Titel:
Palifermin reduces severe oral mucositis (OM), improves patient quality of life, and reduces health resource use in patients with hematologic malignancies receiving high-dose chemotherapy (HDCT) and total body irradiation (TBI) with autologous peripheral blood stem cell (PBSC) support: results from a phase III trial
Auteur:
Bensinger, W. Weisdorf, D. Gentile, T. Cesano, A. Elhardt, D. Emmanouilides, C. Erder, M.H. Hansen, K. Isitt, J. Kewalramani, T. McCarty, J. Noga, S. Rong, A. Shea, T. Spielberger, R. Yanovich, S. Stiff, P.
Verschenen in:
Biology of blood and marrow transplantation
Paginering:
Jaargang 10 (2004) nr. S1 pagina's 1 p.
Jaar:
2004
Inhoud:
Uitgever:
Published by Elsevier B.V.
Bronbestand:
Elektronische Wetenschappelijke Tijdschriften
Details van artikel 204 van 305 gevonden artikelen